lonza,原代细胞和干细胞,Cord Blood CD34+ ≥2 million cells

2022年3月25日 作者 jinpanbio
Catalog #: 2C-101X

Cryopreserved ampule of Human Cord Blood CD34+ stem/progenitors containing ≥2 million cells

 

This product is also available with HLA information if your research requires it:
≥1 million cells 
≥ 2 million cells 

Overview

Product Overview

Lonza cord blood CD34+ cells (2C-101X) contain hematopoietic stem and progenitor cells, are isolated from cord blood mononuclear cells (MNCs) via positive immunomagnetic separation. They are ideal for studies relating to transplantation and stem cells and humanized mouse model development. The number of cells typically obtained from cord blood can be limiting and pose a challenge. Cord blood derived CD34+ (2C-101X) consists of ≥2 million cells hematopoietic stem cells from the same donor. Cells are ethically sourced and are isolated using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. Large inventory supports stable supply from a single vendor.

Guarantee

Lonza guarantees the performance of Cells only if appropriate Lonza recommended Media and Reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support.

Benefits

More cells: Increase productivity with larger number of cells available from a single donor

High Purity Viability: Guaranteed to have a purity of ≥90% as indicated by CD34+ expression

High viability: They are guaranteed to contain ≥2 million viable cells per ampoule

Certificate of Analysis is provided for each cell lot purchased. HIV, HBV, HCV not detected

Supporting media: Use X-VIVO® 20 Medium for the expansion and differentiation.

Choices in CD34+ cell types: (2C-101 H) and 2C-101 HX are available with HLA information. CD34+ cells derived from bone marrow (2M-101) and from adult mobilized blood (4Y-101D) are also available.

Applications

  • Humanized mice models creation 
  • CAR-T therapy process development 
  • Regenerative medicine 
  • Autoimmune disease 
  • Transplantations studies 
  • Immunology 
  • Cancer research

Instructions, SDS, CoA

Instructions

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

1  of 

Cord Blood CD34+ ≥2  million cells

Safety Data Sheets (SDS)

View SDS

SDS – Dutch
SDS – German
SDS – Italian
SDS – Spanish
SDS – French
SDS – English

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Related Products
Cord Blood CD34+ ≥2  million cells
Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 1 Million 4Y-101C

See details

Cord Blood CD34+ ≥2  million cells
Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 100,000 2M-101

See details

Cord Blood CD34+ ≥2  million cells
Human Cord Blood CD34+ Stem/Progenitor Cells, Cryopreserved, 1 Million cells with HLA 2C-101H

See details

Cord Blood CD34+ ≥2  million cells
Cord Blood CD34+ ≥2 million cells w/ HLA 2C-101HX

See details

Cord Blood CD34+ ≥2  million cells
Human Cord Blood CD34+ Progenitor Cells, Cryopreserved, 500,000 cells 2C-101A

See details

Educational Material

Brochures, White Papers etc.

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

1  of 

Cord Blood CD34+ ≥2  million cells

Data

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

Cord Blood CD34+ ≥2  million cells

1  of 

Cord Blood CD34+ ≥2  million cells

FAQ & Citations